Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025421 · ClinicalTrials.gov registry record · NA

The ARISE Study - Use of Vertical Positioning

A NA study of Acute Respiratory Distress Syndrome, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07025421 is a NA study of Acute Respiratory Distress Syndrome that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 366-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025421, a NA study of Acute Respiratory Distress Syndrome, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position

Interventions

  • OTHER Intervention Upright Bed positioning

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-08-25
Est. Completion 2026-08-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07025421

The ClinicalTrials.gov registry entry for NCT07025421 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 366-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (89% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Respiratory Distress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Intervention Upright Bed positioning is the first listed.

NCT07025421 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07025421 about?

NCT07025421 is a clinical study titled "The ARISE Study - Use of Vertical Positioning". The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position

What is the current status of trial NCT07025421?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-25. Estimated completion is 2026-08-31.

What conditions does trial NCT07025421 study?

This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome.

What interventions are being tested in trial NCT07025421?

The interventions under investigation include: Intervention Upright Bed positioning (OTHER).

Who is sponsoring clinical trial NCT07025421?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025421 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Distress Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.